Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 49 - Preparations for testing in vivo
Patents for A61K 49 - Preparations for testing in vivo (35,376)
10/2003
10/30/2003US20030202940 Assessment of concentration of inhalational compounds in the brain
10/30/2003US20030202939 Forming oxygen free radicals; destroying tumor, cancer
10/30/2003US20030201208 Dynamic superparamagnetic markers
10/30/2003CA2482029A1 Peptide deformylase activated prodrugs
10/30/2003CA2481724A1 Screening and therapeutic methods for treating circadian rhythm disorders
10/29/2003EP1356826A1 Microparticles comprising carbohydrate beads covalently linked with allergen
10/29/2003EP1356284A2 Schizophrenia related genes
10/29/2003EP1356050A2 Fluorescent proteins
10/29/2003EP1356038A2 Compositions and methods relating to lung specific genes and proteins
10/29/2003EP1355921A2 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof
10/29/2003EP1355919A2 Molecules with extended half-lives, compositions and uses thereof
10/29/2003EP1355913A1 Paramagnetic metal-phthalocyanine complex compounds and contrast agent using the same
10/29/2003EP1355637A2 Inhibitors of matriptase for the treatment of cancer
10/29/2003EP0968000B1 Administrable compositions and methods for magnetic resonance imaging
10/29/2003EP0946526B1 Macrocyclic metal complex carboxylic acids, use and method for the production thereof
10/29/2003CN1125654C Methods of preparing gas and gaseous precursor filled microspheres
10/28/2003US6639061 C3′-methylene hydrogen phosphonate oligomers and related compounds
10/28/2003US6638913 Concentrated injection and infusion solution for intravenous administration
10/28/2003US6638508 Drug delivery; therapy for liver disorders
10/28/2003US6638495 Stabilized preparation for use in metered dose inhalers
10/28/2003US6638494 Iron hydroxide, ferric hydrate, iron oxide, iron mixed oxide or iron; di- or polycarboxylic acid stabilizer; aggregation prevention; antitumor and contrast agents; immune boosters, magnetic resonance imaging, cell fusion, gene transfer
10/28/2003US6638207 Radioactive seed with multiple markers and method for using same
10/23/2003WO2003087302A2 Dual-labeled nucleotides
10/23/2003WO2003087165A2 Biocompatible materials and probes
10/23/2003WO2003086563A2 Diabetes imaging probes
10/23/2003WO2003086475A1 Conjugates comprising cancer cell specific ligands, a sugar and diagnostic agents, and uses thereof
10/23/2003WO2003086474A2 Fluorinated or paramagnetic alginate polymer, annexin paramagnetic conjugate, and their use as contrasting agent in mri
10/23/2003WO2003086324A2 Preparation and use of a stable formulation of allosteric effector compounds
10/23/2003WO2003086299A2 Quantitative assay of the angiogenic and antiangiogenic activity of a test molecule
10/23/2003WO2003086178A2 Methods for inhibiting vascular hyperpermeability
10/23/2003WO2003086172A2 Method for tagging colonic residue
10/23/2003WO2003055379A3 Method using a surface-selective nonlinear optical technique for imaging of biological samples
10/23/2003WO2003032902A3 Tumor targeted photodiagnostic-phototherapeutic agents
10/23/2003WO2002068000A3 Polymeric imagable brachytherapy seed
10/23/2003WO2001040519A8 Methods for identifying modulators for balance related disorders
10/23/2003US20030199687 Biocompatible materials and probes
10/23/2003US20030199679 Recombinant antibodies specific for TNF-alpha
10/23/2003US20030199469 Contacting tumor cells with modulating agent and with an antitumor therapeutic agent known to cause apotosis; determining degree of apoptosis of tumor cells; comparing degree of apoptosis with degree of apoptosis of tumor cells
10/23/2003US20030198599 Novel imaging probes
10/23/2003US20030198597 Measuring intensity of signal; calibration
10/23/2003CA2481692A1 Method for tagging colonic residue
10/23/2003CA2481669A1 Preparation and use of a stable formulation of allosteric effector compounds
10/23/2003CA2480809A1 Methods for inhibiting vascular hyperpermeability
10/22/2003EP1354214A2 Mri method involving the use of a hyperpolarized contrast agent
10/22/2003EP1354062A2 Target activated nucleic acid biosensor and methods of using same
10/22/2003EP1353899A1 A process for the preparation of iopamidol and the new intermediates therein
10/22/2003EP1353703A2 Visual marker for determining compliance with a medication regimen
10/22/2003EP1353659A1 Use of neurotoxic substances in producing a medicament for treating joint pains
10/22/2003EP1194441B1 A2a receptor agonists
10/22/2003EP0928809B1 Polysaccharide derivative/magnetic metal oxide composite
10/22/2003CN1451046A 保守的奈瑟球菌抗原 Conservative Neisseria antigen
10/22/2003CN1451043A Dual specificity antibodies and methods of making and using
10/22/2003CN1450915A Matrix metalloproteinase inhibitors as targeting components in diagnostic agents
10/22/2003CN1125083C Monoclonal antibody active against CD44V6
10/21/2003US6636755 Method and apparatus for obtaining an optical tomographic image of a sentinel lymph node
10/21/2003US6635235 Bifunctional chelating agent for the design and development of site specific radiopharmaceuticals and biomolecule conjugation strategy
10/16/2003WO2003085125A1 Use of biomolecular targets in the treatment and visualization of brain tumors
10/16/2003WO2003084582A1 Embolization
10/16/2003WO2003084574A1 Multivalent constructs for therapeutic and diagnostic applications
10/16/2003WO2003084399A1 Endohedral metallofullerene contrast agents
10/16/2003WO2003084386A2 Methods for ultrasonic imaging and treating diseased tissues
10/16/2003WO2003011342A3 Targeted polymeric delivery systems
10/16/2003WO2002083110A3 Animal model for evaluating analgesics
10/16/2003WO2002060941A9 Fluorescent proteins
10/16/2003US20030195417 Medical optical imaging scanner using multiple wavelength simultaneous data acquisition for breast imaging
10/16/2003US20030195349 H. pylori flbA polypeptides, immunogenic and vaccinating compositions comprising H. pylori flbA polypeptides, and compositions for detection of an infection comprising H. pylori flbA polypeptides
10/16/2003US20030194739 Using cancer specific genes
10/16/2003US20030194453 Dietary supplement
10/16/2003US20030194443 External solid phase containing a polyhydroxyalkanoate and an internal phase that is a second solid phase, a liquid phase or a gaseous phase; drugs, agricultural products, cosmetics
10/16/2003US20030194376 Aqueous solution and surfactant stabilized microbubbles comprising halogenated hydrocarbon; echography
10/16/2003US20030194374 High speed dissolve layer when exposed to saliva; drug delivery of orally administrable medicine
10/16/2003CA2779639A1 Multivalent constructs for therapeutic and diagnostic applications
10/16/2003CA2480579A1 Embolization
10/16/2003CA2477935A1 Multivalent constructs for therapeutic and diagnostic applications
10/16/2003CA2477298A1 Use of biomolecular targets in the treatment and visualization of brain tumors
10/15/2003EP1351990A2 Compositions and methods for detecting proteolytic activity
10/15/2003EP1351699A1 Methods for improved diagnosis and treatment of mycobacterial infections
10/15/2003EP1351671A1 Triphenylmethane kinesin inhibitors
10/15/2003EP0876140B1 Improved kontrast agent solutions for intravenous administration
10/15/2003CN1449375A Use of pamoic acid or one of derivatives or analogs thereof for preparing a medicament used for treating diseases
10/15/2003CN1124284C High-effective broad-spectrum antibody for inhibiting growth and metastasis of tumour
10/14/2003US6632979 Genetically engineered animal for use in the prevention, detection, diagnosis and treatment of mammary gland cancer
10/14/2003US6632923 Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
10/14/2003US6632176 Products and methods for brachytherapy
10/14/2003CA2317019C Magnetically responsive composition
10/14/2003CA2098242C Surface modified anticancer nanoparticles
10/09/2003WO2003083436A2 Fibrinogen binding moieties
10/09/2003WO2003083102A2 Cancer associated protein phosphatases and their uses
10/09/2003WO2003082988A1 Nir-fluorescent cyanine dyes, their synthesis and biological use
10/09/2003WO2003082250A1 Processes for manufacturing polymeric microspheres
10/09/2003WO2003082117A1 Device and method for quantifying bodies by means of ultrasound
10/09/2003WO2003082105A1 Paramagnetic particles that provide improved relaxivity
10/09/2003WO2003081997A1 CALPAIN LARGE SUBUNIT (n-CL4) CYSTEINE PROTEASE GENE DISRUPTIONS, AND COMPOSITIONS AND METHODS RELATED THERETO
10/09/2003WO2003060463A3 Methods of screening, determining, developing, and utilizing negative cross resistance toxins
10/09/2003WO2002047680A9 Use of tocopherol, metabolites or derivatives thereof or flavonoid metabolites or derivatives thereof in the manufacture of a medicament for the treatment of tissue ischemia
10/09/2003US20030191446 Booster for therapy of diseases with ultrasound and pharmaceutical liquid composition containing the same
10/09/2003US20030190676 In which covalently modified antibody takes on the binding specificity of a targeting agent
10/09/2003US20030190653 Regulated gene in the pathophysiology of ischemic stroke
10/09/2003US20030190368 Identification of cellular activation factors and their use as diagnostic markers
10/09/2003US20030190311 Immunoglobulins; fusion proteins; vaccines
1 ... 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 ... 354